Accurate staging of non-small cell lung cancer-tissue is the issue

Neal Navani^{1

2}

Affiliations

Comment

Neal Navani. J Thorac Dis. 2019 Aug.

. 2019 Aug;11(8):E141-E143.

doi: 10.21037/jtd.2019.07.62.

Neal Navani^{1

2}

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Lung cancer staging: accuracy is critical.
Jantz MA. Jantz MA. J Thorac Dis. 2019 May;11(Suppl 9):S1322-S1324. doi: 10.21037/jtd.2019.04.18. J Thorac Dis. 2019. PMID: 31245122 Free PMC article. No abstract available.

1. Navani N, Fisher DJ, Tierney JF, et al. The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer: An Analysis Based on Individual Participant Data. Chest 2019;155:502-9. 10.1016/j.chest.2018.10.020 - DOI - PMC - PubMed
1. Heineman DJ, Ten Berge MG, Daniels JM, et al. The Quality of Staging Non-Small Cell Lung Cancer in the Netherlands: Data From the Dutch Lung Surgery Audit. Ann Thorac Surg 2016;102:1622-9. 10.1016/j.athoracsur.2016.06.071 - DOI - PubMed
1. Fischer B, Lassen U, Mortensen J, et al. Preoperative Staging of Lung Cancer with Combined PET-CT. N Engl J Med 2009;361:32-9. 10.1056/NEJMoa0900043 - DOI - PubMed
1. Mazzone PJ, Vachani A, Chang A, et al. Quality indicators for the evaluation of patients with lung cancer. Chest 2014;146:659-69. 10.1378/chest.13-2900 - DOI - PMC - PubMed
1. Maconachie R, Mercer T, Navani N, et al. Lung cancer: diagnosis and management: summary of updated NICE guidance. BMJ 2019;364:l1049. 10.1136/bmj.l1049 - DOI - PubMed